metabolicMolecular Weight: 4813.5

Tirzepatide

Mounjaro • Zepbound

A novel dual agonist for GLP-1 and GIP receptors, used for weight management and diabetes.

Shop Tirzepatide

Mechanism

Dual GLP-1 and GIP receptor agonist. Improves glycemic control and promotes significant weight loss.

Half-Life

5 days

Administration

Subcutaneous

Technical Protocol

Tirzepatide: Comprehensive Research Guide

Overview

Tirzepatide is a dual GLP-1 and GIP receptor agonist approved for type 2 diabetes and chronic weight management. It represents one of the most effective weight loss medications ever developed.

Mechanism of Action

Activates both GLP-1 and GIP receptors
Promotes significant weight loss (15-20% body weight)
Improves glycemic control
Reduces appetite and food intake

This information is for research and educational purposes only.

Peer-Reviewed Citations

Tirzepatide once weekly for the treatment of obesity

Jastreboff AM, et al. • N Engl J Med (2022)

Access Research

Frequently Asked Questions

What is Tirzepatide?

A novel dual agonist for GLP-1 and GIP receptors, used for weight management and diabetes.

How does Tirzepatide work?

Dual GLP-1 and GIP receptor agonist. Improves glycemic control and promotes significant weight loss.

What is the typical dosage of Tirzepatide in research?

The typical research dosage of Tirzepatide is 5 mg weekly (range: 2.5-15 mg weekly). Common administration routes include Subcutaneous.

How should Tirzepatide be stored?

Store at 2-8°C, protect from light

Source Tirzepatide for Your Research

Third-party tested, EU-shipped, certificate of analysis included. High-purity Tirzepatide available from our verified research partner.